Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05979935
Other study ID # 20230726-QiluH
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date July 1, 2023
Est. completion date April 2024

Study information

Verified date July 2023
Source Qilu Hospital of Shandong University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The goal of this observational study is to compare the tongue bioinformatics of high-risk and low-risk patients with esophageal varices due to liver cirrhosis. The main question of this study is to explore whether there exists a relationship between the degree of esophageal varices and tongue bioinformatics in liver cirrhosis. it aims to answer 2 questions as below: question 1: If these is a significant difference in tongue bioinformatics between patients in liver cirrhosis with high-risk and low-risk of esophageal varices. Question 2; If tongue bioinformatics can be used as a diagnostic basic for testing esophageal varices in liver cirrhosis. Firstly, participants will be divided into two groups according to their degree of esophageal varices from electronic gastroscopy report and CT scan report including high-risk group and low-risk group. Secondly, participants will be asked to show their tongue, including the surface and sublingual veins of tongue, and the tongue images of each participants will be collected by researchers via camera. After finishing tongue image collection, participants will receive a professional tongue diagnosis report in Traditional Chinese Medicine and health suggestion.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 300
Est. completion date April 2024
Est. primary completion date December 29, 2023
Accepts healthy volunteers
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: 1. Patient with liver cirrhosis has been diagnosed according to clinical manifestations, blood test and imaging examination. 2. Patient with abdominal enhanced CT scans and upper gastrointestinal endoscopy, 3. Patient who has signed informed consent forms. Exclusion Criteria: 1. Patient who has previously received endoscopic treatment, transjugular intrahepatic portosystemic shunt (TIPS), splenectomy, Hepatectomy, balloon occlusion of retrograde veins or liver transplantation. 2. Patient with severe ascites or Hepatic encephalopathy is painted. 3. Patient with concurrent primary liver cancer; 4. Patient with concurrent severe infection of other systems; 5. Patient with symptoms of liver cirrhosis subside after antiviral treatment; 6. Patient who is taking beta receptor blockers; 7. Paitent with mental disorders;

Study Design


Intervention

Diagnostic Test:
tongue diagnosis
The tongue image of participants will be collected via camera and professional tongue diagnosis report will be provided to pariticipants.

Locations

Country Name City State
China Qilu Hospital of Shdong University Jinan Shandong

Sponsors (5)

Lead Sponsor Collaborator
Qilu Hospital of Shandong University 960th Hospital of PLA, Jinan Central Hospital, Qianfoshan Hospital, Shandong Provincial Hospital

Country where clinical trial is conducted

China, 

References & Publications (4)

He C, Liao Q, Fu P, Li J, Zhao X, Zhang Q, Gui Q. Microbiological characteristics of different tongue coatings in adults. BMC Microbiol. 2022 Sep 9;22(1):214. doi: 10.1186/s12866-022-02626-7. — View Citation

Lin Y, Li L, Yu D, Liu Z, Zhang S, Wang Q, Li Y, Cheng B, Qiao J, Gao Y. A novel radiomics-platelet nomogram for the prediction of gastroesophageal varices needing treatment in cirrhotic patients. Hepatol Int. 2021 Aug;15(4):995-1005. doi: 10.1007/s12072- — View Citation

Ou J, Li R, Zeng R, Wu CQ, Chen Y, Chen TW, Zhang XM, Wu L, Jiang Y, Yang JQ, Cao JM, Tang S, Tang MJ, Hu J. CT radiomic features for predicting resectability of oesophageal squamous cell carcinoma as given by feature analysis: a case control study. Cance — View Citation

Tandon M, Singh H, Singla N, Jain P, Pandey CK. Tongue thickness in health vs cirrhosis of the liver: Prospective observational study. World J Gastrointest Pharmacol Ther. 2020 Aug 8;11(3):59-68. doi: 10.4292/wjgpt.v11.i3.59. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Esophageal varices is diagnosed by electronic gastroscopy Electronic gastroscopy is a standard method to diagnosis esophageal varices for patients with cirrhosis. Especially, the electronic gastroscopy can detect the degree of esophageal varices detallly, including the diameter and red sign of varices veins. 6 months
Primary Tongue images analysis by artificial intelligence Tongue images of participants will be analyzed by using artificial intelligence technology. And the result will be used to test If tongue bioinformatics is related to the degree of esophageal varices in liver cirrhosis. 6 months
Secondary Specific Characteristic in Tongue Bioinformatics Artificial intelligence technology and statistic analysis will be used to study the specific difference in tongue bioinformatics between high-risk and low-risk group esophageal varices in patients with liver cirrhosis. 6 months
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05055713 - A Randomized Controlled Study on the Treatment of Cirrhosis Combined With Hypersplenism N/A
Recruiting NCT02945930 - Study the Safety and Efficacy of "Compont Medical Glue" in the Treatment of Esophagogastric Varices N/A
Completed NCT04823780 - The Effects of Early Enteral Nutrition on Endoscopic Therapy of Esophagogastric Varices in Liver Cirrhosis
Completed NCT03244332 - HEMOCC Study. Hemostasis in Cirrhotic Children. N/A
Completed NCT02991612 - Rifaximin in Patients With Gastroesophageal Variceal Bleeding N/A
Recruiting NCT02964195 - Efficacy of Rifaximin in Treatment of Cirrhotic Gastroesophageal Variceal Bleeding N/A
Completed NCT00004641 - A Study to Prevent Complications of High Blood Pressure Caused by Hepatitis in Patients With Cirrhosis Phase 2
Completed NCT02593799 - Non-invasive Prediction of Esophageal Varices in Liver Cirrhosis: A Multicenter Observational Study
Recruiting NCT02719119 - Trial of Monthly Versus Bi-weekly Endoscopic Variceal Ligation for the Prevention of Esophageal Variceal Rebleeding N/A
Recruiting NCT02385422 - The Effect of Carvedilol Vs Propranolol in Cirrhotic Patients With Variceal Bleeding Phase 4
Completed NCT00838864 - Comparison of 3 Days and 7 Days Intravenous Ceftriaxone Prophylaxis for Variceal Bleeding Phase 4
Not yet recruiting NCT03130127 - Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis N/A
Recruiting NCT02504723 - Carvedilol as an Adjunct to Endoscopic Cyanoacrylate Injection for Secondary Prophylaxis of Gastric Variceal Bleeding Phase 4
Withdrawn NCT00475592 - Validation of Esophageal Variceal Grading: A Comparative Study of Upper Gastrointestinal (GI) Endoscopy and Capsule Endoscopy N/A
Completed NCT05331768 - Comparison of Endoscopic Band Ligation Plus 24-hour Versus 72-hour Terlipressin Therapy N/A
Completed NCT04210297 - Development and Validation of an Noninvasive Model for Predicting High Risk Esophageal Varices in Cirrhosis
Recruiting NCT02311608 - Effects of Terlipressin When Usual Somatostatin or Octreotide Dose Fails N/A
Completed NCT04976543 - Safety of Anticoagulant Therapy After Endoscopic Treatment Phase 4
Not yet recruiting NCT05978752 - Clinical Study on Endoscopic Management of GOV1 Esophagogastric Varices N/A
Recruiting NCT02695732 - The Effect of Carvedilol VS Endoscopic Therapy in Primary Prophylaxis of High-risk Esophageal Gastric Variceal Bleeding Phase 4